Oncology Associates of Oregon — Eugene, Oregon

Public research footprint of Oncology Associates of Oregon, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung · Non-Small Cell Lung Cancer · NSCLC (Advanced Non-small Cell Lung Cancer) · Ovarian Cancer

Recently updated registry entries

NCT07266441 — A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma (Recruiting)
NCT06667076 — A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With… (Recruiting)
NCT07174336 — A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Oncology Associates of Oregon?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.